Boston Common Asset Management, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,126 filers reported holding NOVARTIS A G in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.

Quarter-by-quarter ownership
Boston Common Asset Management, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$19,096
-2.0%
187,472
-2.9%
0.46%
+9.6%
Q2 2023$19,493
+9.1%
193,168
-0.5%
0.42%
+11.8%
Q1 2023$17,865
-22.8%
194,188
-23.9%
0.37%
-66.4%
Q4 2022$23,137
-99.9%
255,039
-6.9%
1.11%
+1.5%
Q3 2022$20,826,000
-11.8%
273,988
-1.9%
1.09%
-7.3%
Q2 2022$23,617,000
+15.4%
279,396
+19.8%
1.18%
+33.1%
Q1 2022$20,465,000
+30.0%
233,216
+29.6%
0.88%
+39.0%
Q4 2021$15,738,000
+9.9%
179,923
+2.8%
0.64%
+2.7%
Q3 2021$14,319,000
-5.5%
175,090
+5.5%
0.62%
-4.9%
Q2 2021$15,146,000
+12.6%
166,004
+5.5%
0.65%
-23.3%
Q1 2021$13,449,000
-3.2%
157,331
+6.9%
0.85%
-12.5%
Q4 2020$13,894,000
+11.0%
147,131
+2.2%
0.97%
-18.5%
Q3 2020$12,519,000
-11.8%
143,960
-11.4%
1.19%
-21.5%
Q2 2020$14,196,000
+6.4%
162,541
+0.4%
1.52%
-19.5%
Q1 2020$13,347,000
-9.7%
161,883
+3.7%
1.88%
+9.3%
Q4 2019$14,781,000
+9.0%
156,103
+0.1%
1.72%
+2.9%
Q3 2019$13,555,000
-12.3%
155,988
-7.9%
1.67%
-13.1%
Q2 2019$15,460,000
-16.5%
169,314
-12.1%
1.93%
-19.9%
Q1 2019$18,516,000
+12.0%
192,596
-0.0%
2.40%
-0.3%
Q4 2018$16,532,000
+21.5%
192,658
+22.0%
2.41%
+42.8%
Q3 2018$13,610,000
+13.3%
157,960
-0.6%
1.69%
+13.5%
Q2 2018$12,008,000
+5.0%
158,960
+12.4%
1.49%
+10.4%
Q1 2018$11,431,000
+2.0%
141,383
+5.9%
1.35%
+1.3%
Q4 2017$11,211,000
-2.3%
133,529
-0.1%
1.33%
-7.1%
Q3 2017$11,478,000
+4.6%
133,693
+1.7%
1.43%
-1.0%
Q2 2017$10,977,000
+8.9%
131,508
-3.1%
1.44%
+5.4%
Q1 2017$10,083,000
-0.6%
135,765
-2.5%
1.37%
-7.4%
Q4 2016$10,141,000
-20.6%
139,223
-13.9%
1.48%
+112.9%
Q3 2016$12,774,000
-6.7%
161,773
-2.5%
0.70%
-11.6%
Q2 2016$13,685,000
+3.5%
165,857
-9.1%
0.79%
+5.1%
Q1 2016$13,224,000
-18.0%
182,555
-2.6%
0.75%
-17.5%
Q4 2015$16,134,000
-7.7%
187,520
-1.4%
0.91%
-14.9%
Q3 2015$17,475,000
-8.4%
190,107
-2.0%
1.07%
+5.3%
Q2 2015$19,084,000
-17.9%
194,059
-17.7%
1.01%
-18.4%
Q1 2015$23,252,000
+3.9%
235,799
-2.4%
1.24%
-1.0%
Q4 2014$22,377,000
-1.2%
241,494
+0.4%
1.25%
-0.9%
Q3 2014$22,640,000
+6.0%
240,520
+2.0%
1.26%
+8.5%
Q2 2014$21,353,000
+7.0%
235,868
+0.5%
1.16%
+3.2%
Q1 2014$19,947,000
+4.0%
234,616
-1.7%
1.13%
+5.4%
Q4 2013$19,180,000
+2.8%
238,612
-1.9%
1.07%
-0.7%
Q3 2013$18,666,000
+7.1%
243,332
-1.3%
1.08%
-0.6%
Q2 2013$17,432,000246,5221.08%
Other shareholders
NOVARTIS A G shareholders Q1 2021
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders